Results

Total Results: over 10,000 records

Showing results for "women".
Users also searched for: patient experience

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
    July 01, 2014 - These circumstances compromise the health of both the woman and her fetus.4,5 Although causation has … for women taking SSRIs but within recommended limits for women who did not receive SSRIs. … Knowing the best course of action when a woman is diagnosed with depression during these times is extremely … treated with an SSRI than in untreated pregnant women. … Why Pregnant Women Deserve Drug Trials. Body Politic [Blog].
  2. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/osteoporosis-screening-2002
    September 17, 2002 - Older women have a much higher fracture rate than younger women with the same bone density because of … On a quality-of-life questionnaire, women with osteoporosis voiced significantly more fears than women … older women without risk factors. … error of densitometry would likely exceed the estimated bone loss in such a brief period. 126 After a woman … Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/4zmYnqJXLv8g4LzLrrDDrm
    December 01, 2014 - The preeclampsia incidence rate would be approximately �8% in a pregnant woman with �1 of these risk … than in non-Hispanic white women. … populations of black women. … Studies of low- or average-risk pregnant women were included with trials of women at increased risk ( … Nine trials (6 in women at increased preeclampsia risk and 3 in women at low risk; 22 760 women in total
  4. CERs Report cover (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - drugs specific to cancer pathways 62.5% 8 Aromatase Inhibitors 54.5% 8 What factors influence a woman … Studies of what factors influence a woman‟s decision-making about medications to reduce breast cancer … drugs specific to cancer pathways 62.5% 8 Aromatase Inhibitors 54.5% 8 What factors influence a woman … A2: What is the most effective method to determine a woman‟s risk for breast cancer? … A2: What is the most effective method to determine a woman‟s risk for breast cancer?
  5. CERs Report cover (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - drugs specific to cancer pathways 62.5% 8 Aromatase Inhibitors 54.5% 8 What factors influence a woman … Studies of what factors influence a woman‟s decision-making about medications to reduce breast cancer … drugs specific to cancer pathways 62.5% 8 Aromatase Inhibitors 54.5% 8 What factors influence a woman … A2: What is the most effective method to determine a woman‟s risk for breast cancer? … A2: What is the most effective method to determine a woman‟s risk for breast cancer?
  6. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
    June 26, 2018 - -year-old white woman who has no additional risk factors (B recommendation). 6 The USPSTF concluded … In addition, women receiving estrogen plus progestin, compared with women receiving placebo, were found … Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass … ) Women Any OF None 1 37 (n = 506) 0.65 (NR) Women Hip h Hip BMD 4 37 , 43 … 0.68 (NR) Women Nonvertebral Hip BMD 1 59 (n = 1646) 0.62 (NR) Women Nonvertebral
  7. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
    June 26, 2018 - -year-old white woman who has no additional risk factors (B recommendation). 6 The USPSTF concluded … In addition, women receiving estrogen plus progestin, compared with women receiving placebo, were found … Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass … ) Women Any OF None 1 37 (n = 506) 0.65 (NR) Women Hip h Hip BMD 4 37 , 43 … 0.68 (NR) Women Nonvertebral Hip BMD 1 59 (n = 1646) 0.62 (NR) Women Nonvertebral
  8. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
    December 15, 2013 - those for annual mammography in a descriptive study conducted in the United Kingdom (MRI, 11.0% per woman-year … Women using tamoxifen and raloxifene had more thromboembolic events than women using placebo (tamoxifen … A prospective cohort study of women with BRCA mutations indicated that none of 75 women with risk-reducing … † Testing may be done on the unaffected woman, the relative with cancer, or the relative with the … Testing may be done on the unaffected woman or her relative with cancer as appropriate.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - It is the second most common cause of cancer-related death in women, killing over 40,000 women each … , premenopausal women, and women who have comorbid conditions or are taking additional medications … researchers, funders, and clinicians were interested in the molecular and genetic basis that places a woman … “One published paper in African American women . . . none for Hispanic women. … Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - It is the second most common cause of cancer-related death in women, killing over 40,000 women each … , premenopausal women, and women who have comorbid conditions or are taking additional medications … researchers, funders, and clinicians were interested in the molecular and genetic basis that places a woman … “One published paper in African American women . . . none for Hispanic women. … Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving
  11. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-false-positive-and-false-negative-rates-of-/breast-cancer-screening-january-2016
    January 11, 2016 - for additional imaging (124.9 per 1000 women [CI, 109.3 to 142.3]) were highest among women aged 40 … the BCSC data do not include information on types of menopausal hormone therapy, we assumed that a woman … with a uterus uses combination therapy and a woman without a uterus uses estrogen-only therapy, as previously … Women aged 70 to 79 years had the highest rates of invasive cancer (7.2 per 1000 women [CI, 6.4 to … † Percentage of 241,728 screened women aged 40–59 y; women aged ≥60 y are postmenopausal.
  12. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-harms-of-screening-for-breast-cancer/breast-cancer-screening-january-2016
    January 11, 2016 - women with dense breasts. … Anxiety lessens over time for most women but persists for others, and some women with false-positive … A randomized screening trial of mammography in women age 40 to 49 years. … Psychologic distress in women with abnormal findings in mass mammography screening. … Women screened vs. not screened Multiple statistical adjustments Cohort of women born 1903–1907
  13. digital.ahrq.gov/sites/default/files/docs/publication/r21hs022114-shorten-final-report-2016.pdf
    January 01, 2016 - There were 55 women who provided responses to Survey 2 and of these 39 women provided feedback on the … Women who identified as black were less likely to use the decision aid (44.4% of women accessing the … decision aid web-site we explored the variable of change in knowledge score (S2 – S1 score) for each woman … For the 52 women completing before and after surveys, knowledge score increased for 42 women (80.8%) … , decreased for five women (9.6%) and remained the same for five women (9.6%).
  14. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/womenhealth/2014nhqdr-womenhealth.pptx
    January 01, 2020 - In 10 of 11 years, non-Hispanic Black women were more likely than non-Hispanic White women to report … In 2012, Asian and Pacific Islander (API) women were less likely than White women to have potentially … recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescent girls … with 69.5% of White women. … For those with any college, the percentages were 76.3% for Asian women and 86.5% for White women.
  15. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/womenhealth/2014nhqdr-womenhealth.pptx
    January 01, 2020 - In 10 of 11 years, non-Hispanic Black women were more likely than non-Hispanic White women to report … In 2012, Asian and Pacific Islander (API) women were less likely than White women to have potentially … recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescent girls … with 69.5% of White women. … For those with any college, the percentages were 76.3% for Asian women and 86.5% for White women.
  16. digital.ahrq.gov/sites/default/files/docs/citation/r18hs017093-schwarz-final-report-2011.pdf
    January 01, 2011 - Women seen by clinicians in the intervention groups will report more satisfaction than women seen by … included the warning statement “Consider chance of pregnancy when prescribing” in bold text, unless the womanWomen who preferred to complete the survey by phone were able to do so. … Women wanted clear information about all potential fetal outcomes. … Contraceptive Counseling and Use among Women with Poor Health.
  17. digital.ahrq.gov/sites/default/files/docs/publication/k08hs017951-rand-final-report-2015.pdf
    January 01, 2015 - However, if poor and minority women have lower rates of vaccination than those in higher income groups … A recent national study found that Black women, compared with white women, had 50% higher odds of infection … with HPV.11 Women living below the poverty line had a 36% higher risk compared to those three or more … factors combine to make it imperative to ensure widespread HPV immunization for inner-city adolescent girls … Condom use and the risk of genital human papillomavirus infection in young women.
  18. www.qualitymeasures.ahrq.gov/research/findings/nhqrdr/2014chartbooks/womenhealth/wm-hl2.html
    September 01, 2015 - Elderly Low-Income Racial/Ethnic Minorities Rural/Inner-City Residents Special Healthcare Needs Women … Living: Infant Mortality Healthy Living: HPV Vaccine Among Adolescent Females Health Living: Adult Women … recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescent girls
  19. ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/2014chartbooks/womenhealth/wm-hl2.html
    September 01, 2015 - Elderly Low-Income Racial/Ethnic Minorities Rural/Inner-City Residents Special Healthcare Needs Women … Living: Infant Mortality Healthy Living: HPV Vaccine Among Adolescent Females Health Living: Adult Women … recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescent girls
  20. psnet.ahrq.gov/issue/global-knowledge-sharing-platform-patient-safety
    July 14, 2021 - December 12, 2023 Maternal Health of Women and Girls of African Descent in the Americas